Literature DB >> 20051075

Prevalence of negative birth perception, disaffirmation, perinatal trauma symptoms, and depression among postpartum women.

Dianna Spies Sorenson, Lois Tschetter.   

Abstract

PURPOSE: This study documented new case and estimated annual case prevalence, and relationships among women's negative birth perceptions, provider disaffirmation, perinatal trauma symptoms, and depression at 6-7 months postpartum. DESIGN AND METHODS: An exploratory investigation of 71 White women (20.8% of the total population) was conducted. CONCLUSIONS. New case prevalence of negative birth perceptions (9.6:100), perinatal trauma symptoms (10.2:100), disaffirmation (8.6:100), and depression (15.7:100) are greater than other prominent high burden diseases. Variables were significantly correlated. PRACTICE IMPLICATIONS: Findings reinforce the need for psychiatric liaison advanced practice nurses caring for childbearing women, including roles for detection/screening, educating professionals in communication, legislative/advocacy for funding, and further research.

Entities:  

Mesh:

Year:  2010        PMID: 20051075     DOI: 10.1111/j.1744-6163.2009.00234.x

Source DB:  PubMed          Journal:  Perspect Psychiatr Care        ISSN: 0031-5990            Impact factor:   2.186


  18 in total

1.  Association between stillbirth ≥23 weeks gestation and acute psychiatric illness within 1 year of delivery.

Authors:  Adam K Lewkowitz; Joshua I Rosenbloom; Matt Keller; Julia D López; George A Macones; Margaret A Olsen; Alison G Cahill
Journal:  Am J Obstet Gynecol       Date:  2019-06-19       Impact factor: 8.661

Review 2.  Post-traumatic stress disorder in the perinatal period: A concept analysis.

Authors:  Julie Vignato; Jane M Georges; Ruth A Bush; Cynthia D Connelly
Journal:  J Clin Nurs       Date:  2017-05-23       Impact factor: 3.036

3.  Measuring post-traumatic stress after childbirth: a review and critical appraisal of instruments.

Authors:  Meagan E Williams; Donna M Strobino; Charvonne N Holliday
Journal:  J Reprod Infant Psychol       Date:  2022-01-27

4.  Stressful events during pregnancy and postpartum depressive symptoms.

Authors:  Sarah Lederberg Stone; Hafsatou Diop; Eugene Declercq; Howard J Cabral; Matthew P Fox; Lauren A Wise
Journal:  J Womens Health (Larchmt)       Date:  2015-03-09       Impact factor: 2.681

5.  Does CenteringPregnancy Group Prenatal Care Affect the Birth Experience of Underserved Women? A Mixed Methods Analysis.

Authors:  Rhianon Liu; Maria T Chao; Ariana Jostad-Laswell; Larissa G Duncan
Journal:  J Immigr Minor Health       Date:  2017-04

6.  Association Between Severe Maternal Morbidity and Psychiatric Illness Within 1 Year of Hospital Discharge After Delivery.

Authors:  Adam K Lewkowitz; Joshua I Rosenbloom; Matt Keller; Julia D López; George A Macones; Margaret A Olsen; Alison G Cahill
Journal:  Obstet Gynecol       Date:  2019-10       Impact factor: 7.661

Review 7.  Peripartum depression and anxiety as an integrative cross domain target for psychiatric preventative measures.

Authors:  Jessica A Babb; Kristina M Deligiannidis; Christopher A Murgatroyd; Benjamin C Nephew
Journal:  Behav Brain Res       Date:  2014-04-04       Impact factor: 3.332

8.  Childbirth and symptoms of postpartum depression and anxiety: a prospective birth cohort study.

Authors:  A F Bell; C S Carter; J M Davis; J Golding; O Adejumo; M Pyra; J J Connelly; L H Rubin
Journal:  Arch Womens Ment Health       Date:  2015-07-23       Impact factor: 3.633

Review 9.  A systematic review of the relationship between severe maternal morbidity and post-traumatic stress disorder.

Authors:  Marie Furuta; Jane Sandall; Debra Bick
Journal:  BMC Pregnancy Childbirth       Date:  2012-11-10       Impact factor: 3.007

10.  Differences in mouse maternal care behavior - is there a genetic impact of the glucocorticoid receptor?

Authors:  Sabine Chourbaji; Carolin Hoyer; S Helene Richter; Christiane Brandwein; Natascha Pfeiffer; Miriam A Vogt; Barbara Vollmayr; Peter Gass
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.